These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Prognosis
15 results:

  • 1. Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study.
    Qi LN; Ma L; Wu FX; Chen YY; Xu JX; Peng YC; Chen ZS; Gong WF; Yang CL; Wei HW; Qin SL; Shang JJ; Wang QY; Yu HP; Peng T; Huang YW; Ling YC; Tang WZ; Xiang BD; Li LQ
    Liver Int; 2022 Oct; 42(10):2283-2298. PubMed ID: 35810457
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic significance of high mobility group A2 (hmga2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic hmga2 expression.
    Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network.
    Xi Y; Jing Z; Wei W; Chun Z; Quan Q; Qing Z; Jiamin X; Shuwen H
    BMC Cancer; 2021 Feb; 21(1):127. PubMed ID: 33549042
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of the Effects of Aspirin and Sulindac Sulfide on the Inhibition of hmga2-Mediated Oncogenic Capacities in colorectal cancer.
    Ekanem TI; Tsai WL; Lin YH; Tan WQ; Chang HY; Huang TC; Chen HY; Lee KH
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32842685
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Dicoumarol suppresses hmga2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer.
    Chen CH; Hsieh YC; Yang PM; Liu YR; Cho EC
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1003-1009. PubMed ID: 32063361
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of hmga2 in colorectal cancer.
    Huang YM; Cheng CH; Pan SL; Yang PM; Lin DY; Lee KH
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684108
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Anti-colorectal cancer Effect via Application of Polyethylene Glycol Modified liposomal Apatinib.
    Hu Y; Zhou P; Lin Y; Yang D; Wang B
    J Biomed Nanotechnol; 2019 Jun; 15(6):1256-1266. PubMed ID: 31072433
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through hmga2 signaling.
    Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
    Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Overexpression of miR-194 Reverses hmga2-driven Signatures in colorectal cancer.
    Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
    Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating hmga2.
    Yu FY; Tu Y; Deng Y; Guo C; Ning J; Zhu Y; Lv X; Ye H
    Cancer Biol Ther; 2016 Nov; 17(11):1149-1157. PubMed ID: 27686621
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
    Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transcriptional activation of FN1 and IL11 by hmga2 promotes the malignant behavior of colorectal cancer.
    Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
    Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
    Lee CT; Wu TT; Lohse CM; Zhang L
    Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The expression of hmga2 varies strongly among colon carcinomas.
    Helmke BM; Markowski DN; Meyer A; Bullerdiek J
    Anticancer Res; 2012 May; 32(5):1589-93. PubMed ID: 22593436
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Gene expressions of hmgi-c and HMGI(Y) are associated with stage and metastasis in colorectal cancer.
    Huang ML; Chen CC; Chang LC
    Int J Colorectal Dis; 2009 Nov; 24(11):1281-6. PubMed ID: 19609535
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.